Above all, data must be connected to be usable. Entity Resolution (ER) plays a crucial role in connecting disparate data. ER ...
Q4 sales & FY 2024 resultsSales & Ebita margin in line with revised guidance 2024; FCF conversion exceeding objective Positive North ...
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Q4 2024 Earnings Call February 12, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne - ...
This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...